NCT00742352Unknown不适用
PET FDG Assessment of Change in Atherosclerotic Plaques After Chemotherapy
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to determine whether chemotherapy induces regression in atherosclerotic plaques in oncologic patients already undergoing PET FDG as part of their routine assessment.We will use PET FDG to assess whether the inflammation in atherosclerotic plaques is affected by chemotherapy and anti angiogenic therapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Women over the age of 65 diagnosed with metastatic breast cancer
- •Men over the age of 65 diagnosed with lung cancer
排除标准
- •Patients under the age of 65
- •Patients diagnosed with chronic inflammatory disease or chronic infection
- •Patients taking steroids and NSAIDS on a regular basis
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque InflammationAtherosclerosisNCT00114504Kurume University43
撤回
不适用
Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)AtherosclerosisNCT00926055Korea University
Unknown
不适用
Pitavastatin on Carotid Intima-media ThicknessCarotid Artery DiseasesHyperlipidemiaNCT00711919Kyoto Prefectural University of Medicine300
已完成
3 期
Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)Cardiovascular DiseasesCoronary DiseaseHeart DiseasesMyocardial IschemiaNCT00000488National Heart, Lung, and Blood Institute (NHLBI)
已完成
2 期
Efficacy and Safety of Pactimibe in Patients With AtherosclerosisAtherosclerosisNCT00185146Sankyo Pharma Gmbh200